GlassScriptPhysician profile
Kathleen M Powers
NPI 1861692774
$4,621.53
in general payments reported to CMS, 2019-2025
26 companies · $845 in 2025
The $845 reported for 2025 was more than what 82% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,228 · 2023: $1,061 · 2024: $1,487 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,393.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $792.69 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $460.35 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Aimmune Therapeutics, INC. | $419.03 | 2024-2025 | Zenpep |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $373.54 | 2022-2024 | Caplyta |
| Abbott Laboratories | $359.76 | 2022-2025 | Freestyle Libre 3 |
| Corcept Therapeutics | $328.16 | 2024-2025 | Korlym |
| Novo Nordisk INC | $280.25 | 2022-2025 | Ozempic, Rybelsus |
| Biohaven Pharmaceutical Holding Company LTD. | $270.82 | 2022 | |
| Nestle Healthcare Nutrition INC. | $219.15 | 2022-2023 | |
| Lilly USA, LLC | $187.60 | 2023-2024 | Zepbound, Jardiance, Jaypirca |
| Phathom Pharmaceuticals, INC. | $160.86 | 2024 | Voquezna |
| Exact Sciences Corporation | $159.29 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.20 | 2022-2024 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $78.08 | 2022-2023 | Austedo |
| Boston Scientific Corporation | $75.76 | 2024 | Embold Fibered |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $69.35 | 2023-2025 | Rexulti |
| Lundbeck LLC | $49.04 | 2023-2025 | Rexulti |
| Medtronic, INC. | $47.55 | 2022 | |
| Sanofi-Aventis U.S. LLC | $47.50 | 2024-2025 | |
| Radius Health, INC. | $38.44 | 2024 | |
| Glaxosmithkline, LLC. | $29.68 | 2023-2024 | Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $20.71 | 2025 | |
| Sumitomo Pharma America, INC. | $16.74 | 2025 | Gemtesa |
| Axsome Therapeutics, INC. | $15.14 | 2022 | |
| Eisai INC. | $14.52 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.